-
ALS Organizations Collaborate to Advance New Therapeutic into Trials
About Anelixis Therapeutics ALS TDI created Anelixis Therapeutics in 2012 as a for-profit clinical development subsidiary to develop AT-...
2018-12-03 17:36 -
ICMR to conduct trials of indigenously developed Zika vaccine
Vaccines manufacturer, Hyderabad-based Bharat Biotech, has developed a vaccine, which they claim will provide protection against infecti...
2018-11-28 16:26 -
Impact of GST has largely been positive and constructive on pharma sector
Discontinuation of Central Sales Tax post-GST, he added, will reduce transaction costs, as inter-state transaction between two dealers w...
2018-11-28 16:19 -
Chi-Med announces first commercial launch of fruquintinib capsules (Elunate)
Dr Wang Li, Senior Vice President, Head of Lilly China Drug Development & Medical Affairs Center, said: “We look forward to working with...
2018-11-27 16:44 -
Wacker rebrands newly acquired pharma protein facility in the Netherlands
Wacker said SynCo Bio Partners’ expertise in manufacturing live microbial biopharmaceuticals adds to its knowhow as a full-service supplier.
2018-11-22 14:57 -
Lupin gets inspection report from USFDA for Nagpur facility
USFDA gives EIR on closure of inspection of an establishment that is the subject of an FDA or FDA-contracted inspection.
2018-11-22 10:58 -
'Indian ayurveda sector set to grow at 16% CAGR over next 5 years'
Rajiv Vasudevan, Chairman, CII Core Group of Ayurveda and CEO AyurVAID Hospital noted that unless Ayurveda is implemented in government ...
2018-11-22 10:44 -
Global glioblastoma market set to reach $1.4bn by 2027
GlobalData’s latest report states that a drive to address the high level of unmet needs will be hindered by difficulties in clinical development, lea...
2018-11-16 17:20 -
Crown Bioscience expands cardiovascular and metabolic diseaseresearch capability
The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana
2018-11-16 16:43 -
Non-small cell lung cancer market projected to be worth $14.6 billion by 2024
Following the recent spate of approvals in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), the treatment landscape is becom...
2018-11-16 16:41
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- The Truth Behind the US-China ... Jun 30, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products
Related Producers
